🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the effect of immunotherapy with ipilimumab an...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2023-10-25
Trial ID
NCT05836571
The study object of this clinical trial is CanProFem-AK, 100 mg suppositori...
Status
Completed
Location
MIPO Clinic LLP
Start Date
2024-06-01
Trial ID
NCT06535126
Treatments Being Tested
Children with chronic kidney disease, even after transplantation, may be at...
Status
Completed
Location
McMaster Children's Hospital
Start Date
2014-09
Trial ID
NCT02126293
Treatments Being Tested
Patients who are being asked to participate in this study have a short smal...
Status
Completed
Location
Northwestern Memorial Hospital
Start Date
2006-10
Trial ID
NCT01380366
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453
Hyponatremia is a frequent complication of subarachnoid hemorrhage (SAH) wi...
Status
Unknown
Location
Hopital Femme Mère Enfant
Start Date
2022-10-01
Trial ID
NCT05942755
This phase Ib/II trial compares the effect of teclistamab and pomalidomide ...
Status
Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2027-04-12
Trial ID
NCT07463807
Kidney dysfunction before and immediately after liver transplantation is co...
Status
Completed
Location
Royal Infirmary of Edinburgh
Start Date
2018-01-15
Trial ID
NCT03376009
This phase I trial studies the side effects and best dose of TAK-243 in tre...
Status
Suspended
Location
Moffitt Cancer Center
Start Date
2025-03-12
Trial ID
NCT03816319
The purposes of the research trial are to study the safety of ABY-029 and t...
Status
Recruiting
Location
Dartmouth-Hitchcock Medical Center
Start Date
2026-02-17
Trial ID
NCT07063693
Treatments Being Tested